122 related articles for article (PubMed ID: 17517688)
1. Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study.
Brennan P; McKay J; Moore L; Zaridze D; Mukeria A; Szeszenia-Dabrowska N; Lissowska J; Rudnai P; Fabianova E; Mates D; Bencko V; Foretova L; Janout V; Chow WH; Rothman N; Chabrier A; Gaborieau V; Odefrey F; Southey M; Hashibe M; Hall J; Boffetta P; Peto J; Peto R; Hung RJ
Hum Mol Genet; 2007 Aug; 16(15):1794-801. PubMed ID: 17517688
[TBL] [Abstract][Full Text] [Related]
2. Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers.
Cybulski C; Masojc B; Oszutowska D; Jaworowska E; Grodzki T; Waloszczyk P; Serwatowski P; Pankowski J; Huzarski T; Byrski T; Górski B; Jakubowska A; Debniak T; Wokolorczyk D; Gronwald J; Tarnowska C; Serrano-Fernández P; Lubinski J; Narod SA
Carcinogenesis; 2008 Apr; 29(4):762-5. PubMed ID: 18281249
[TBL] [Abstract][Full Text] [Related]
3. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
[TBL] [Abstract][Full Text] [Related]
4. A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer.
Zhang S; Lu J; Zhao X; Wu W; Wang H; Lu J; Wu Q; Chen X; Fan W; Chen H; Wang F; Hu Z; Jin L; Wei Q; Shen H; Huang W; Lu D
Carcinogenesis; 2010 Jul; 31(7):1251-8. PubMed ID: 20462940
[TBL] [Abstract][Full Text] [Related]
5. A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking.
Liang G; Miao X; Zhou Y; Tan W; Lin D
Carcinogenesis; 2004 May; 25(5):773-8. PubMed ID: 14688021
[TBL] [Abstract][Full Text] [Related]
6. CHEK2 mutations and HNPCC-related colorectal cancer.
Suchy J; Cybulski C; Wokołorczyk D; Oszurek O; Górski B; Debniak T; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dziuba I; Gogacz M; Wiśniowski R; Wandzel P; Banaszkiewicz Z; Kurzawski G; Kładny J; Narod SA; Lubiński J
Int J Cancer; 2010 Jun; 126(12):3005-9. PubMed ID: 19876921
[TBL] [Abstract][Full Text] [Related]
7. CHEK2 variant I157T may be associated with increased breast cancer risk.
Kilpivaara O; Vahteristo P; Falck J; Syrjäkoski K; Eerola H; Easton D; Bartkova J; Lukas J; Heikkilä P; Aittomäki K; Holli K; Blomqvist C; Kallioniemi OP; Bartek J; Nevanlinna H
Int J Cancer; 2004 Sep; 111(4):543-7. PubMed ID: 15239132
[TBL] [Abstract][Full Text] [Related]
8. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
Wang H; Tan W; Hao B; Miao X; Zhou G; He F; Lin D
Cancer Res; 2003 Nov; 63(22):8057-61. PubMed ID: 14633739
[TBL] [Abstract][Full Text] [Related]
9. The associations of sequence variants in DNA-repair and cell-cycle genes with cancer risk: genotype-phenotype correlations.
Hall J; Marcel V; Bolin C; Fernet M; Tartier L; Vaslin L; Hainaut P
Biochem Soc Trans; 2009 Jun; 37(Pt 3):527-33. PubMed ID: 19442246
[TBL] [Abstract][Full Text] [Related]
10. Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract.
Buch S; Zhu B; Davis AG; Odom D; Siegfried JM; Grandis JR; Romkes M
Mol Carcinog; 2005 Apr; 42(4):222-8. PubMed ID: 15754315
[TBL] [Abstract][Full Text] [Related]
11. Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism.
Miller DP; De Vivo I; Neuberg D; Wain JC; Lynch TJ; Su L; Christiani DC
Int J Cancer; 2003 May; 104(6):758-63. PubMed ID: 12640684
[TBL] [Abstract][Full Text] [Related]
12. The CHEK2*1100delC allelic variant and risk of breast cancer: screening results from the Breast Cancer Family Registry.
Bernstein JL; Teraoka SN; John EM; Andrulis IL; Knight JA; Lapinski R; Olson ER; Wolitzer AL; Seminara D; Whittemore AS; Concannon P
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):348-52. PubMed ID: 16492927
[TBL] [Abstract][Full Text] [Related]
13. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
14. Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations.
Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Debniak T; Wokolorczyk D; Jakubowska A; Serrano-Fernández P; Dork T; Narod SA; Lubinski J
J Med Genet; 2009 Feb; 46(2):132-5. PubMed ID: 18930998
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers.
Ariyoshi N; Miyamoto M; Umetsu Y; Kunitoh H; Dosaka-Akita H; Sawamura Y; Yokota J; Nemoto N; Sato K; Kamataki T
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):890-4. PubMed ID: 12223434
[TBL] [Abstract][Full Text] [Related]
16. The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysis.
Han FF; Guo CL; Liu LH
DNA Cell Biol; 2013 Jun; 32(6):329-35. PubMed ID: 23713947
[TBL] [Abstract][Full Text] [Related]
17. CHEK2 I157T and endometrial cancer.
Konstantinova DV; Kadiyska TK; Kaneva RP; Tosheva EG; Guseva VT; Dimitrov BH; Dimitrov RG; Doganov NI; Ivanov SI; Kremensky IM; Mitev VI
DNA Cell Biol; 2009 Jan; 28(1):9-12. PubMed ID: 18834326
[TBL] [Abstract][Full Text] [Related]
18. p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer.
Husgafvel-Pursiainen K; Boffetta P; Kannio A; Nyberg F; Pershagen G; Mukeria A; Constantinescu V; Fortes C; Benhamou S
Cancer Res; 2000 Jun; 60(11):2906-11. PubMed ID: 10850436
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer.
Park JY; Lee SY; Jeon HS; Bae NC; Chae SC; Joo S; Kim CH; Park JH; Kam S; Kim IS; Jung TH
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):23-7. PubMed ID: 11815397
[TBL] [Abstract][Full Text] [Related]
20. Association of two mutations in the CHEK2 gene with breast cancer.
Bogdanova N; Enssen-Dubrowinskaja N; Feshchenko S; Lazjuk GI; Rogov YI; Dammann O; Bremer M; Karstens JH; Sohn C; Dörk T
Int J Cancer; 2005 Aug; 116(2):263-6. PubMed ID: 15810020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
